Vaccines

Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines

David Dodd; Mark Newman, Ph.D.

GeoVax Inc.

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

Prof. Dr. Ulrike Fiedler

IDT Biologika

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

COVID-19 Vaccines

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

Cynthia A. Challener, Ph.D.

Pharma's Almanac

COVID-19 Vaccines

The Global Immunization Disparity

Komal Hatti

IPS-Integrated Project Services, LLC

COVID-19 Vaccine

AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material

AGC Biologics

COVID-19 Vaccine

FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine

Brand Institute

Thermal Packaging

With Omicron Variant on the Rise, Thermal Custom Packaging (TCP) is Providing Secure Transportation of COVID Vaccine

Thermal Custom Packaging

Collaboration

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001

IDT Biologika

Viral Vaccines

Viral Vectors, Vaccines — A New Era Of Collaborative Design

Andreas Neubert, Ph.D.

IDT Biologika

Gene Therapy

Pandemic Playbook for Gene Therapy Manufacturing

Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.

MilliporeSigma

COVID-19 Vaccine

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

Novavax, Inc.

Cleanrooms

Rapid Cleanroom Builds for COVID-19 Facilities: Lessons Learned

Grant Merrill; Jose Jimenez

AES Clean Technology Inc.

Genetic Vaccines

Working to Overcome Analytical Challenges Posed by Genetic Vaccines

Cynthia A. Challener, Ph.D.

Pharma's Almanac

COVID-19

Preparing for the Next Pandemic: Lessons Learned from COVID-19

Sheila Rocchio

eClinical Solutions

COVID-19 Vaccine

Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo

Pfizer

COVID-19 Vaccine

Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial

Sanofi

Vaccines

A Look at Genetic Vaccine Development and Manufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

COVID-19 Vaccines

The COVID-19 Vaccine Journey Continues

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Emergency Use

Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents

Pfizer: Breakthroughs That Change Patients’ Lives